Target Price | $381.69 |
Price | $324.61 |
Potential | 17.59% |
Number of Estimates | 36 |
36 Analysts have issued a price target Visa 2026 . The average Visa target price is $381.69. This is 17.59% higher than the current stock price. The highest price target is $410.00 26.31% , the lowest is $310.00 4.50% . | |
A rating was issued by 44 analysts: 33 Analysts recommend Visa to buy, 9 to hold and 2 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Visa stock has an average upside potential 2026 of 17.59% . Most analysts recommend the Visa stock at Purchase. |
34 Analysts have issued a sales forecast Visa 2025 . The average Visa sales estimate is $39.6b . This is 7.51% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $40.0b 8.80% , the lowest is $39.0b 6.07% .
This results in the following potential growth metrics:
2024 | $35.9b | 10.02% |
---|---|---|
2025 | $39.6b | 10.13% |
2026 | $43.6b | 10.22% |
2027 | $47.8b | 9.63% |
2028 | $54.0b | 13.01% |
26 Analysts have issued an Visa EBITDA forecast 2025. The average Visa EBITDA estimate is $27.9b . This is 8.20% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $29.3b 13.76% , the lowest is $27.3b 5.96% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $25.2b | 9.73% |
---|---|---|
2025 | $27.9b | 10.64% |
2026 | $30.9b | 10.68% |
2027 | $34.0b | 10.33% |
2028 | $38.2b | 12.24% |
2024 | 70.13% | 0.26% |
---|---|---|
2025 | 70.45% | 0.46% |
2026 | 70.75% | 0.43% |
2027 | 71.20% | 0.64% |
2028 | 70.71% | 0.69% |
23 Visa Analysts have issued a net profit forecast 2025. The average Visa net profit estimate is $21.7b . This is 13.47% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $22.2b 16.24% , the lowest is $21.1b 10.42% .
This results in the following potential growth metrics and future Net Margins:
2024 | $18.7b | 17.67% |
---|---|---|
2025 | $21.7b | 15.84% |
2026 | $24.8b | 14.06% |
2027 | $28.1b | 13.24% |
2028 | $33.2b | 18.20% |
2024 | 52.19% | 6.95% |
---|---|---|
2025 | 54.89% | 5.18% |
2026 | 56.80% | 3.48% |
2027 | 58.68% | 3.31% |
2028 | 61.37% | 4.58% |
23 Analysts have issued a Visa forecast for earnings per share. The average Visa EPS is $11.11 . This is 13.48% higher than earnings per share in the financial year 2024. The highest EPS forecast is $11.38 16.24% , the lowest is $10.81 10.42% .
This results in the following potential growth metrics and future valuations:
2024 | $9.59 | 17.67% |
---|---|---|
2025 | $11.11 | 15.85% |
2026 | $12.67 | 14.04% |
2027 | $14.35 | 13.26% |
2028 | $16.96 | 18.19% |
Current | 33.16 | 2.35% |
---|---|---|
2025 | 29.22 | 11.88% |
2026 | 25.62 | 12.32% |
2027 | 22.62 | 11.71% |
2028 | 19.14 | 15.38% |
Based on analysts' sales estimates for 2025, the Visa stock is valued at an EV/Sales of 16.11 and an P/S ratio of 16.03 .
This results in the following potential growth metrics and future valuations:
Current | 17.32 | 3.59% |
---|---|---|
2025 | 16.11 | 7.01% |
2026 | 14.61 | 9.27% |
2027 | 13.33 | 8.78% |
2028 | 11.79 | 11.52% |
Current | 17.23 | 3.22% |
---|---|---|
2025 | 16.03 | 6.99% |
2026 | 14.54 | 9.27% |
2027 | 13.26 | 8.78% |
2028 | 11.74 | 11.52% |
Analyst | Rating | Action | Date |
---|---|---|---|
Evercore ISI Group |
➜
In-Line
|
Initiated | Apr 09 2025 |
Susquehanna |
Positive
➜
Positive
|
Unchanged | Feb 21 2025 |
Barclays |
Overweight
➜
Overweight
|
Unchanged | Feb 03 2025 |
B of A Securities |
Neutral
➜
Neutral
|
Unchanged | Jan 31 2025 |
Wells Fargo |
Overweight
➜
Overweight
|
Unchanged | Jan 31 2025 |
Goldman Sachs |
Buy
➜
Buy
|
Unchanged | Jan 31 2025 |
JP Morgan |
Overweight
➜
Overweight
|
Unchanged | Jan 31 2025 |
Analyst Rating | Date |
---|---|
Initiated
Evercore ISI Group:
➜
In-Line
|
Apr 09 2025 |
Unchanged
Susquehanna:
Positive
➜
Positive
|
Feb 21 2025 |
Unchanged
Barclays:
Overweight
➜
Overweight
|
Feb 03 2025 |
Unchanged
B of A Securities:
Neutral
➜
Neutral
|
Jan 31 2025 |
Unchanged
Wells Fargo:
Overweight
➜
Overweight
|
Jan 31 2025 |
Unchanged
Goldman Sachs:
Buy
➜
Buy
|
Jan 31 2025 |
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
Jan 31 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.